Adults 18 to 75, any sex, with CRC. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Performance of MCS in Cleansing a Poorly Prepared Colon.Primary· Up to 2 hours
The rate of adequate cleansing level per subject will be evaluated by the Boston Bowel Preparation (BBPS) scoring index before and post the cleansing operation.
adequate cleaning after the use of MCS
Group
Value
95% CI
Colonoscopy With MCS
46
adequate cleaning at baseline
Group
Value
95% CI
Colonoscopy With MCS
9
Adverse events — posted to ClinicalTrials.gov
Time frame: Follow up was conducted immediately after the procedure before patient discharge and at 2-3 days and 14-16 days post procedure.
Reporting threshold: 5%.
Adverse-event reports describe events observed during the trial — not all are caused by the drug.
The study is multi-center study ,planned as a single arm, open trial, aimed at evaluating the performance and safety of a colon cleansing device during a colonoscopy procedure in a poorly prepared colons.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT06682793 — A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumor
· Phase 1, PHASE2
· recruiting
NCT07204574 — The Phase 1b/IIa, Open-label, Dose Escalation and Dose Expansion to Evaluate Safety, Tolerability, and Preliminary Effic
· Phase 1, PHASE2
· recruiting
NCT06728072 — Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer
· Phase 2
· recruiting
NCT06445062 — Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
· Phase 1, PHASE2
· recruiting
NCT05382377 — NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors
· EARLY_PHASE1
· recruiting
Other Motus GI Medical Technologies Ltd trials
Trials by the same sponsor.
NCT05585879 — Demonstrating Effective Salvage of Inadequate Colonoscopies
· NA
· terminated
NCT04285008 — Randomized Controlled Study Comparing Colon Evaluation With The Pure-Vu System To A Standard Colonoscopy In Patients Who
· NA
· withdrawn
NCT03922906 — Evaluation of Bowel Cleansing Using the Pure-Vu System in Patients With History of Inadequate Bowel Preparation
· NA
· terminated
NCT03503162 — Evaluation of the Bowel Cleansing in Hospitalized Patients Using Pure-Vu System
· NA
· completed
NCT03493009 — Optimizing the Preparation Regime Prior to Colonoscopy Procedure With Pure-Vu System
· NA
· withdrawn
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Motus GI Medical Technologies Ltd
Last refreshed: 11 February 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03026075.